Litigation Details for Pfizer Inc. v. Mylan Pharmaceuticals Inc. (D. Del. 2015)
✉ Email this page to a colleague
Pfizer Inc. v. Mylan Pharmaceuticals Inc. (D. Del. 2015)
Docket | ⤷ Sign Up | Date Filed | 2015-01-23 |
Court | District Court, D. Delaware | Date Terminated | |
Cause | 35:271 Patent Infringement | Assigned To | Gregory Moneta Sleet |
Jury Demand | None | Referred To | |
Patents | 6,858,650; 7,384,980; 7,855,230; 7,985,772 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Pfizer Inc. v. Mylan Pharmaceuticals Inc.
Details for Pfizer Inc. v. Mylan Pharmaceuticals Inc. (D. Del. 2015)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2017-08-09 | 89 | attendant FDA regulations, U.S. Patent Nos. 6,858,650 (the '"650 patent"), 7,384,980 (the ยท'…;772 patent), and 8,338,4 78 (the '" 4 78 patent") (collectively, the "patents-in-suit…'"980 patent"), 7,855,230 (the "'230 patent"), 7,985,772 (the "'… The Patents-in-Suit 11. Collectively, the '980, '230, '772, and '478 patents may …-ed to as the "Compound Patents." 12. The Compound Patents each issued from common parent | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |